| Name | lysosomal protein transmembrane 4 beta |
| Description | Enables ceramide binding activity; enzyme binding activity; and phosphatidylinositol bisphosphate binding activity. Involved in several processes, including endosome transport via multivesicular body sorting pathway; negative regulation of macromolecule metabolic process; and regulation of lysosomal membrane permeability. Located in several cellular components, including endosome; lysosomal membrane; and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nLysosome‐associated protein transmembrane 4 beta (LAPTM4B) has emerged as a multifunctional regulator of lysosomal activity and intracellular signaling. Early studies demonstrated that LAPTM4B facilitates the recruitment of amino acid transporters to lysosomes, thereby promoting leucine uptake and activating mTORC1 in response to essential amino acids."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In parallel, LAPTM4B modulates endosomal receptor trafficking—by impeding the ubiquitination of sorting proteins, it delays EGFR degradation"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "—and interacts with partners in regulatory T cells to temper TGF‐β production."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, LAPTM4B is critical for lysosome homeostasis; it sustains autophagic flux and exosome secretion by maintaining membrane integrity and facilitating ceramide export from late endosomal compartments"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in cell homeostasis, LAPTM4B overexpression is a common feature in numerous malignancies where it drives oncogenic processes. Elevated LAPTM4B promotes cell proliferation, migration, invasion, and multidrug resistance—partly through its physical association with efflux transporters and activation of the PI3K/AKT pathway"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " In breast and ovarian carcinomas, high LAPTM4B levels correlate with aggressive tumor behavior and poor clinical outcome—a link further reinforced by findings that oncogenic transcription factors such as CREB1 and AP4 directly upregulate LAPTM4B expression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Similar oncogenic roles have been documented in non‐small cell lung cancer—where LAPTM4B upregulation is linked to smoking and an enhanced NRF2 stress response"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "—as well as in gliomas, cervical carcinomas, and metastatic breast cancers, where its overexpression signals tumor aggressiveness and resistance to therapy"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nGenetic and clinical profiling studies further underscore the importance of LAPTM4B as both a cancer susceptibility gene and a prognostic marker. Polymorphisms—most notably a tandem duplication in its 5′ untranslated region—have been significantly associated with increased risk of hepatocellular, gastric, colorectal, gallbladder, lung, and other carcinomas"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "38"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "39"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "40"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "41"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "42"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "43"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "44"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "45"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "46"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "47"}]}, {"type": "t", "text": " In addition, early investigations and expanded expression profiling have also hinted at potential roles for LAPTM4B in other disease settings—including alterations in the tissue microenvironment seen in adolescent idiopathic scoliosis—and reinforced its utility as a marker for tumor progression and patient prognosis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "48"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "49"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "50"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ruth Milkereit, Avinash Persaud, Liviu Vanoaica, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms8250"}], "href": "https://doi.org/10.1038/ncomms8250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25998567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25998567"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiaojun Tan, Yue Sun, Narendra Thapa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.201489425"}], "href": "https://doi.org/10.15252/embj.201489425"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25588945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25588945"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Caroline Huygens, Stéphanie Liénart, Olivier Dedobbeleer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.655340"}], "href": "https://doi.org/10.1074/jbc.M115.655340"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26126825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26126825"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yang Li, Qing Zhang, Ruiyang Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-0940"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-0940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22037872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22037872"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Tomas Blom, Shiqian Li, Andrea Dichlberger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B facilitates late endosomal ceramide export to control cell death pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Chem Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nchembio.1889"}], "href": "https://doi.org/10.1038/nchembio.1889"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26280656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26280656"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kohei Yuyama, Hui Sun, Daisuke Mikami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.202001599R"}], "href": "https://doi.org/10.1096/fj.202001599R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33090522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33090522"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "L Li, X H Wei, Y P Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.303"}], "href": "https://doi.org/10.1038/onc.2010.303"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20711237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20711237"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hongtuan Zhang, Shiyong Qi, Tao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3341"}], "href": "https://doi.org/10.18632/oncotarget.3341"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25714029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25714029"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xinrong Liu, Fuxia Xiong, Xuanhui Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2009.01346.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2009.01346.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19843073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19843073"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Min Xiao, Shusheng Jia, Hongbin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B: an independent prognostic marker in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-012-1368-y"}], "href": "https://doi.org/10.1007/s00432-012-1368-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23292099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23292099"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Sha Li, Lu Wang, Yue Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.17176"}], "href": "https://doi.org/10.18632/oncotarget.17176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28476037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28476037"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sha Li, Jian-Jun Xu, Qing-Yun Zhang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14164"}], "href": "https://doi.org/10.1111/cas.14164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31389121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31389121"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Meng Zhang, Jian-Jun Xu, Rou-Li Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "cAMP responsive element binding protein-1 is a transcription factor of lysosomal-associated protein transmembrane-4 Beta in human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0057520"}], "href": "https://doi.org/10.1371/journal.pone.0057520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23469012"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23469012"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yue Meng, Lu Wang, Jianjun Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12171"}], "href": "https://doi.org/10.1002/1878-0261.12171"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29337428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29337428"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lu Wang, Yue Meng, Jian-Jun Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "LAPTM4B"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-17-0519"}], "href": "https://doi.org/10.1158/1541-7786.MCR-17-0519"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29378908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29378908"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Han Tang, Hui Tian, Weiming Yue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-014-0974-8"}], "href": "https://doi.org/10.1007/s12032-014-0974-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24816841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24816841"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yuho Maki, Junya Fujimoto, Wenhua Lang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep13846"}], "href": "https://doi.org/10.1038/srep13846"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26343532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26343532"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiaoshud Dong, Kaoru Tamura, Daisuke Kobayashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35 is a novel prognostic factor for glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-017-2369-0"}], "href": "https://doi.org/10.1007/s11060-017-2369-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28097442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28097442"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Min Xiao, Shanshan Yang, FanLing Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000464115"}], "href": "https://doi.org/10.1159/000464115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28245476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28245476"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yu Yang, Hua Yang, Michael A McNutt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18949404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18949404"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Fanling Meng, Chang Luo, Yuanlong Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PGP.0b013e3181e0898e"}], "href": "https://doi.org/10.1097/PGP.0b013e3181e0898e"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20881850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20881850"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fanling Meng, Xiuwei Chen, Hongtao Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000430216"}], "href": "https://doi.org/10.1159/000430216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26383850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26383850"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Hongying Zhang, Buxian Tian, Hongyu Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35 protein as a potential therapeutic target in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-2599-0"}], "href": "https://doi.org/10.1007/s13277-014-2599-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25416438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25416438"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xin-Rong Liu, Rou-Li Zhou, Qing-Yun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v10.i11.1555"}], "href": "https://doi.org/10.3748/wjg.v10.i11.1555"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15162524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15162524"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Grit Kasper, Anke Vogel, Irina Klaman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2004.10.004"}], "href": "https://doi.org/10.1016/j.canlet.2004.10.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15911104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15911104"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Li-juan Deng, Qing-yun Zhang, Bo Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Beijing Da Xue Xue Bao Yi Xue Ban (2005)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15968325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15968325"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Y Liu, Q-Y Zhang, N Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdl394"}], "href": "https://doi.org/10.1093/annonc/mdl394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17074969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17074969"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "X-J Cheng, W Xu, Q-Y Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdm469"}], "href": "https://doi.org/10.1093/annonc/mdm469"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17965115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17965115"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Li Zhou, Xiao-Dong He, Quan-Cai Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2008.01.025"}], "href": "https://doi.org/10.1016/j.canlet.2008.01.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18334282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18334282"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hua Yang, Fu Xia Xiong, Ming Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-009-0659-4"}], "href": "https://doi.org/10.1007/s00432-009-0659-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19690886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19690886"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hua Yang, Fuxia Xiong, Ruizhao Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jso.21489"}], "href": "https://doi.org/10.1002/jso.21489"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20358632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20358632"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Mingzhu Yin, Cong Li, Xia Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jso.21912"}], "href": "https://doi.org/10.1002/jso.21912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21416470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21416470"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Li Zhou, Xiao-Dong He, Jian-Chun Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Surgery (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.surg.2010.12.010"}], "href": "https://doi.org/10.1016/j.surg.2010.12.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21429547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21429547"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Li Li, Yi Shan, Hua Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anat Rec (Hoboken) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ar.21421"}], "href": "https://doi.org/10.1002/ar.21421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21618708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21618708"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Fanling Meng, Hongtao Song, Chang Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of LAPTM4B polymorphisms with cervical carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.25833"}], "href": "https://doi.org/10.1002/cncr.25833"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21656743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21656743"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "S Wang, Q-Y Zhang, R-L Zhou "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdr538"}], "href": "https://doi.org/10.1093/annonc/mdr538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22156622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22156622"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Mingzhu Yin, Chun Lou, Wang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/IGC.0b013e318234f9ac"}], "href": "https://doi.org/10.1097/IGC.0b013e318234f9ac"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22193644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22193644"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Guojun Zhai, Hua Yang, Xiaoxu Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-011-0139-y"}], "href": "https://doi.org/10.1007/s12032-011-0139-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22207410"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22207410"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Meirong Fan, Ye Liu, Rouli Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of LAPTM4B gene polymorphism with breast cancer susceptibility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canep.2011.12.004"}], "href": "https://doi.org/10.1016/j.canep.2011.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22270081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22270081"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Hua Yang, Guojun Zhai, Xiaoxu Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-012-0173-4"}], "href": "https://doi.org/10.1007/s12032-012-0173-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22302286"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22302286"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Ye Xu, Yunduo Liu, Rouli Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Jpn J Clin Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jjco/hys026"}], "href": "https://doi.org/10.1093/jjco/hys026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22412199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22412199"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Hua Yang, Guojun Zhai, Xiaoxu Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0034984"}], "href": "https://doi.org/10.1371/journal.pone.0034984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22509374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22509374"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Yue Kang, Mingzhu Yin, Wei Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.amjsurg.2012.02.003"}], "href": "https://doi.org/10.1016/j.amjsurg.2012.02.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22578410"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22578410"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "G Zhang, Y Liang, Y Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Int Med Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/147323001204000406"}], "href": "https://doi.org/10.1177/147323001204000406"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22971479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22971479"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Xiaoyan Li, Xiangnan Kong, Xi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0044916"}], "href": "https://doi.org/10.1371/journal.pone.0044916"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22984585"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22984585"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Bing Wang, Jianjun Xu, Rouli Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-013-0470-6"}], "href": "https://doi.org/10.1007/s12032-013-0470-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23345117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23345117"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "Xiaojing Cheng, Zhixue Zheng, Zhaode Bu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0121559"}], "href": "https://doi.org/10.1371/journal.pone.0121559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25849595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25849595"}]}, {"type": "r", "ref": 48, "children": [{"type": "t", "text": "Humam Kadara, Junya Fujimoto, Suk-Young Yoo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/dju004"}], "href": "https://doi.org/10.1093/jnci/dju004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24563515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24563515"}]}, {"type": "r", "ref": 49, "children": [{"type": "t", "text": "Eun Su Moon, Hak Sun Kim, Veushj Sharma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of single nucleotide polymorphism in adolescent idiopathic scoliosis in Korea: for personalized treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Yonsei Med J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3349/ymj.2013.54.2.500"}], "href": "https://doi.org/10.3349/ymj.2013.54.2.500"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23364988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23364988"}]}, {"type": "r", "ref": 50, "children": [{"type": "t", "text": "Hongtuan Zhang, Qiang Wei, Ranlu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0091069"}], "href": "https://doi.org/10.1371/journal.pone.0091069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24651764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24651764"}]}]}]}
|
| Synonyms | LC27, LAPTM4BETA |
| Proteins | LAP4B_HUMAN |
| NCBI Gene ID | 55353 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LAPTM4B has 12,258 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 119 datasets.
Click the + buttons to view associations for LAPTM4B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LAPTM4B gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of LAPTM4B gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of LAPTM4B gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of LAPTM4B gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of LAPTM4B gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of LAPTM4B gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAPTM4B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with LAPTM4B protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with LAPTM4B gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LAPTM4B gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of LAPTM4B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of LAPTM4B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing LAPTM4B protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAPTM4B gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing LAPTM4B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing LAPTM4B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing LAPTM4B protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing LAPTM4B protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with LAPTM4B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with LAPTM4B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAPTM4B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with LAPTM4B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with LAPTM4B gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with LAPTM4B gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with LAPTM4B gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by LAPTM4B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with LAPTM4B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with LAPTM4B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with LAPTM4B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with LAPTM4B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at LAPTM4B gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of LAPTM4B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of LAPTM4B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing LAPTM4B from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with LAPTM4B gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with LAPTM4B gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with LAPTM4B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing LAPTM4B from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of LAPTM4B gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving LAPTM4B gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving LAPTM4B gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving LAPTM4B gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing LAPTM4B protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing LAPTM4B protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing LAPTM4B protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by LAPTM4B gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by LAPTM4B gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by LAPTM4B gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of LAPTM4B gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LAPTM4B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of LAPTM4B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with LAPTM4B gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with LAPTM4B gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with LAPTM4B gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of LAPTM4B gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of LAPTM4B protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for LAPTM4B from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with LAPTM4B gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with LAPTM4B gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by LAPTM4B gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for LAPTM4B protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of LAPTM4B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of LAPTM4B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of LAPTM4B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving LAPTM4B protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LAPTM4B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of LAPTM4B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with LAPTM4B gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of LAPTM4B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of LAPTM4B gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of LAPTM4B gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LAPTM4B gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing LAPTM4B protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain LAPTM4B protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by LAPTM4B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting LAPTM4B gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LAPTM4B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of LAPTM4B gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for LAPTM4B from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LAPTM4B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of LAPTM4B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving LAPTM4B protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving LAPTM4B protein from the Wikipathways PFOCR 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of LAPTM4B gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of LAPTM4B gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of LAPTM4B gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of LAPTM4B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of LAPTM4B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at LAPTM4B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of LAPTM4B gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of LAPTM4B gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of LAPTM4B gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of LAPTM4B gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of LAPTM4B gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of LAPTM4B gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of LAPTM4B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of LAPTM4B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of LAPTM4B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LAPTM4B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of LAPTM4B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of LAPTM4B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with LAPTM4B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with LAPTM4B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |